Cargando…
Human T lymphocytes at tumor sites
CD4(+) and CD8(+) T lymphocytes mediate most of the adaptive immune response against tumors. Naïve T lymphocytes specific for tumor antigens are primed in lymph nodes by dendritic cells. Upon activation, antigen-specific T cells proliferate and differentiate into effector cells that migrate out of p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668216/ https://www.ncbi.nlm.nih.gov/pubmed/36385379 http://dx.doi.org/10.1007/s00281-022-00970-4 |